These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 23704975)

  • 1. Protection against myocardial ischemia-reperfusion injury at onset of type 2 diabetes in Zucker diabetic fatty rats is associated with altered glucose oxidation.
    Povlsen JA; Løfgren B; Dalgas C; Birkler RI; Johannsen M; Støttrup NB; Bøtker HE
    PLoS One; 2013; 8(5):e64093. PubMed ID: 23704975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of diabetes mellitus duration on the efficacy of ischemic preconditioning in a Zucker diabetic fatty rat model.
    Hjortbak MV; Hjort J; Povlsen JA; Jensen RV; Støttrup NB; Laursen MR; Jespersen NR; Løfgren B; Bøtker HE
    PLoS One; 2018; 13(2):e0192981. PubMed ID: 29474385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of hyperglycemia on myocardial ischemia-reperfusion susceptibility and ischemic preconditioning in hearts from rats with type 2 diabetes.
    Kristiansen SB; Pælestik KB; Johnsen J; Jespersen NR; Pryds K; Hjortbak MV; Jensen RV; Bøtker HE
    Cardiovasc Diabetol; 2019 May; 18(1):66. PubMed ID: 31151453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of the malate-aspartate shuttle by pre-ischaemic aminooxyacetate loading of the heart induces cardioprotection.
    Støttrup NB; Løfgren B; Birkler RD; Nielsen JM; Wang L; Caldarone CA; Kristiansen SB; Contractor H; Johannsen M; Bøtker HE; Nielsen TT
    Cardiovasc Res; 2010 Nov; 88(2):257-66. PubMed ID: 20562422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pre-ischaemic mitochondrial substrate constraint by inhibition of malate-aspartate shuttle preserves mitochondrial function after ischaemia-reperfusion.
    Jespersen NR; Yokota T; Støttrup NB; Bergdahl A; Paelestik KB; Povlsen JA; Dela F; Bøtker HE
    J Physiol; 2017 Jun; 595(12):3765-3780. PubMed ID: 28093764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardioprotective effect of L-glutamate in obese type 2 diabetic Zucker fatty rats.
    Povlsen JA; Løfgren B; Rasmussen LE; Nielsen JM; Nørregaard R; Kristiansen SB; Bøtker HE; Nielsen TT
    Clin Exp Pharmacol Physiol; 2009 Sep; 36(9):892-8. PubMed ID: 19298538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rosiglitazone treatment in Zucker diabetic Fatty rats is associated with ameliorated cardiac insulin resistance and protection from ischemia/reperfusion-induced myocardial injury.
    Yue TL; Bao W; Gu JL; Cui J; Tao L; Ma XL; Ohlstein EH; Jucker BM
    Diabetes; 2005 Feb; 54(2):554-62. PubMed ID: 15677515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of altered substrate utilization on cardiac function in isolated hearts from Zucker diabetic fatty rats.
    Wang P; Lloyd SG; Zeng H; Bonen A; Chatham JC
    Am J Physiol Heart Circ Physiol; 2005 May; 288(5):H2102-10. PubMed ID: 15615844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardioprotective effect of succinate dehydrogenase inhibition in rat hearts and human myocardium with and without diabetes mellitus.
    Jespersen NR; Hjortbak MV; Lassen TR; Støttrup NB; Johnsen J; Tonnesen PT; Larsen S; Kimose HH; Bøtker HE
    Sci Rep; 2020 Jun; 10(1):10344. PubMed ID: 32587298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of hypoglycemia on myocardial susceptibility to ischemia-reperfusion injury and preconditioning in hearts from rats with and without type 2 diabetes.
    Pælestik KB; Jespersen NR; Jensen RV; Johnsen J; Bøtker HE; Kristiansen SB
    Cardiovasc Diabetol; 2017 Nov; 16(1):148. PubMed ID: 29121919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mild Type 2 Diabetes Mellitus Reduces the Susceptibility of the Heart to Ischemia/Reperfusion Injury: Identification of Underlying Gene Expression Changes.
    Korkmaz-Icöz S; Lehner A; Li S; Vater A; Radovits T; Hegedűs P; Ruppert M; Brlecic P; Zorn M; Karck M; Szabó G
    J Diabetes Res; 2015; 2015():396414. PubMed ID: 26229969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Berberine Pretreatment Confers Cardioprotection Against Ischemia-Reperfusion Injury in a Rat Model of Type 2 Diabetes.
    Chang W; Li K; Guan F; Yao F; Yu Y; Zhang M; Hatch GM; Chen L
    J Cardiovasc Pharmacol Ther; 2016 Sep; 21(5):486-94. PubMed ID: 26846272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Nitrate Intake on Myocardial Ischemia-Reperfusion Injury in Diabetic Rats.
    Jeddi S; Khalifi S; Ghanbari M; Bageripour F; Ghasemi A
    Arq Bras Cardiol; 2016 Oct; 107(4):339-347. PubMed ID: 27849257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Ischemic Postconditioning on Myocardial Function and Infarct Size Following Reperfusion Injury in Diabetic Rats Pretreated With Vildagliptin.
    Bayrami G; Karimi P; Agha-Hosseini F; Feyzizadeh S; Badalzadeh R
    J Cardiovasc Pharmacol Ther; 2018 Mar; 23(2):174-183. PubMed ID: 28901167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Buffer glucose adjustment affects myocardial function after ischemia-reperfusion in long-term diabetic rat isolated hearts.
    Balzer C; Cleveland WJ; Li Z; Riess ML
    Physiol Rep; 2022 Nov; 10(21):e15387. PubMed ID: 36324287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Onset of diabetes in Zucker diabetic fatty (ZDF) rats leads to improved recovery of function after ischemia in the isolated perfused heart.
    Wang P; Chatham JC
    Am J Physiol Endocrinol Metab; 2004 May; 286(5):E725-36. PubMed ID: 14722022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nitric Oxide/Glucose Transporter Type 4 Pathway Mediates Cardioprotection against Ischemia/Reperfusion Injury under Hyperglycemic and Diabetic Conditions in Rats.
    Al-Kouh A; Babiker F
    J Vasc Res; 2024; 61(4):179-196. PubMed ID: 38952123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AMPK-regulated and Akt-dependent enhancement of glucose uptake is essential in ischemic preconditioning-alleviated reperfusion injury.
    Ji L; Zhang X; Liu W; Huang Q; Yang W; Fu F; Ma H; Su H; Wang H; Wang J; Zhang H; Gao F
    PLoS One; 2013; 8(7):e69910. PubMed ID: 23922853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetes mellitus abrogates erythropoietin-induced cardioprotection against ischemic-reperfusion injury by alteration of the RISK/GSK-3β signaling.
    Ghaboura N; Tamareille S; Ducluzeau PH; Grimaud L; Loufrani L; Croué A; Tourmen Y; Henrion D; Furber A; Prunier F
    Basic Res Cardiol; 2011 Jan; 106(1):147-62. PubMed ID: 20981553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of fatty acids on cardioprotection by pre-ischaemic inhibition of the malate-aspartate shuttle.
    Dalgas C; Povlsen JA; Løfgren B; Erichsen SB; Bøtker HE
    Clin Exp Pharmacol Physiol; 2012 Oct; 39(10):878-85. PubMed ID: 22831462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.